Clinical trial
Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)
NCT04143919 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2020
- Completion date
- June 11, 2021
- Enrollment
- 317 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.